IP Verse

Hexal Pharma Ag competitive analysis

Explore patent oppositions filed by Hexal Pharma Ag against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026

Patent Number	Title	Applicant	Opposition Date
EP3024461	A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation	EURO CELTIQUE	May 14, 2020
EP2941251	Crenolanib For Treating Flt3 Mutated Proliferative Disorders	AROG PHARMACEUTICALS	Dec 7, 2018
EP1785422	Micronised Crystalline Tiotropium Bromide	BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG	Aug 15, 2017
EP2419108	Method For On-Demand Contraception	LABORATOIRE HRA PHARMA	May 15, 2017
EP1301519	Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same	GILEAD SCIENCES	Nov 25, 2015

Discover the latest PTAB cases involving Hexal Pharma Ag, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hexal Pharma Ag with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
HEXAL PHARMA AG	5	-	-	-
AROG PHARMACEUTICALS	-	1	-	-
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG	2	27	-	-
EURO CELTIQUE	-	73	-	-